Literature DB >> 4447860

Metabolism of isoprenaline after aerosol and direct intrabronchial administration in man and dog.

E W Blackwell, R H Briant, M E Conolly, D S Davies, C T Dollery.   

Abstract

1 Administration of isoprenaline by aerosol inhalation to man results in over 80% being metabolized to the sulphate conjugate.2 The majority of an inhaled dose is probably swallowed since the metabolic pattern resembles that after an oral dose.3 Isoprenaline, administered in aqueous solution directly into the bronchial tree in both man and dog, is rapidly O-methylated to 3-O-methyl isoprenaline, which is subsequently conjugated with sulphate.4 3-O-Methylation is the main metabolic pathway for the small part of an inhaled dose which does enter the bronchial tree.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4447860      PMCID: PMC1776727          DOI: 10.1111/j.1476-5381.1974.tb08593.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Metanephrine and normetanephrine in human urine: method and results.

Authors:  E R SMITH; H WEIL-MALHERBE
Journal:  J Lab Clin Med       Date:  1962-08

2.  Metabolism of epinephrine and other sympathomimetic amines.

Authors:  J AXELROD
Journal:  Physiol Rev       Date:  1959-10       Impact factor: 37.312

3.  The chemical estimation of adrenaline-like substances in blood.

Authors:  H WEIL-MALHERBE; A D BONE
Journal:  Biochem J       Date:  1952-06       Impact factor: 3.857

4.  On the occurrence of phenol and steroid sulphokinases in the human gastrointestinal tract.

Authors:  H Boström; D Brömster; H Nordenstam; B Wengle
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

5.  Methyltransferase enzymes in red blood cells.

Authors:  J Axelrod; C K Cohn
Journal:  J Pharmacol Exp Ther       Date:  1971-03       Impact factor: 4.030

6.  Separation of catecholamines and metanephrine and normetanephrine using a weak cation-exchange resin.

Authors:  G L Mattok; D L Wilson
Journal:  Anal Biochem       Date:  1965-06       Impact factor: 3.365

7.  The metabolism of sympathomimetic bronchodilator drugs by the isolated perfused dog lung.

Authors:  R H Briant; E W Blackwell; F M Williams; D S Davies; C T Dollery
Journal:  Xenobiotica       Date:  1973-12       Impact factor: 1.908

8.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

  8 in total
  14 in total

1.  Absorption of drugs by the lung.

Authors:  G M Shenfield; M E Evans; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Dosage and delivery of nebulised beta agonists in hospital.

Authors:  J N Stainforth; R A Lewis; A E Tattersfield
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

Review 4.  Measurement of bronchial reactivity: a question of interpretation.

Authors:  A E Tattersfield
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

5.  Studies of regional ventilation in asthma using 81mKr.

Authors:  F Fazio; A Palla; A Santolicandro; S Solfanelli; E Fornai; C Giuntini
Journal:  Lung       Date:  1979       Impact factor: 2.584

6.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

7.  Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.

Authors:  A J Fairfax; M Rehahn; D Jones; B O'Malley
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 8.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

9.  Effect of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler.

Authors:  S A Gomm; N P Keaney; N J Winsey; T B Stretton
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

Review 10.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.